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Abstract
Background: Ectopic pregnancy remains a major public health problem especially in many developing countries where it is
a significant contributor to pregnancy related morbidity and mortality
Objective: To determine the association between prior Chlamydia trachomatis infection and the risk of  ectopic pregnancy.
Methods: A case-control study from two tertiary health care facilities in Benin City, Nigeria. Ninety eight women with ectopic
pregnancy (cases) and another 98 women with uncomplicated intrauterine pregnancy (controls) matched for age, were
interviewed using a semi-structured questionnaire and evaluated for serological evidence of  prior Chlamydia trachomatis
infection.
Results: The antibody titres in cases (48%) were significantly higher than in controls (16.3%) (p<0.001). However, the
association between Chlamydia antibodies and ectopic pregnancy was attenuated when the effects of indicators of previous
pelvic infections, socio-demographic characteristics, contraceptive and sexual history were controlled for. Primary level of
education (OR = 6.32; CI, 2.31 – 17.3), three or more lifetime sexual partners (OR = 5.71; CI, 2.39 – 13.65) and prior history
of vaginal discharge (OR = 5.00; CI, 2.03 – 12.3) were more likely to be associated with ectopic pregnancy than with the
presence of antibodies to Chlamydia trachomatis (OR = 2.82; 95% CI, 1.33 – 5.95). The Population Attributable Risk was
30.9%.
Conclusion: Chlamydial infections play only a limited role in the pathogenesis of  ectopic pregnancy.
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Introduction
Ectopic pregnancy remains a major public health
problem especially in many developing countries
where it is a significant contributor to pregnancy
related morbidity and mortality1,2.  This view is
sustained by its rising incidence globally3-7. Recent
work from Benin City, Nigeria suggests that the trend
in ectopic pregnancy incidence was that of a yearly
rise1.  Observed increases in ectopic pregnancy have
been attributed to several factors, including increase
in the incidence of pelvic infections and
improvement in the diagnostic techniques for ectopic
pregnancy4. Its increasing incidence globally, has
resulted in growing interest in its aetiology8,9.
A number of studies have looked at the
antibody responses induced by Chlamydia trachomatis
infection and have generally found a good correlation
between serum antibodies to Chlamydia trachomatis
and ectopic pregnancy9-12.  In addition, ectopic
pregnancy risk was observed to be greatest amongst
a subset of women with multiple exposures to
chlamydial infections13. These reports conclude that
Chlamydia trachomatis infection is a major cause of
fallopian tube damage which predisposes to ectopic
pregnancy. However, recent Scandinavian studies
show divergent results concerning the association of
ectopic pregnancy with prior Chlamydia trachomatis
infection14-17.
Whereas the Norwegian studies found a significant
association between previous Chlamydia trachomatis
infection and subsequent ectopic pregnancy14,17, a
reduced risk of ectopic pregnancy after Chlamydia
trachomatis infection was reported from Denmark15
and no association was found in the Swedish study16.
A recent review of  these findings suggests that the
explanation for the discrepant results is the inclusion
of women with diagnosed and hence presumably
treated infections in these Scandinavian registry
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studies18. Again, Andersen et al19 speculated that the
results may be explained by failure to adjust for
confounders such as sexual behaviour and
contraceptive use in these studies. This underscores
the need for new studies on Chlamydia trachomatis
infection and ectopic pregnancy which (as highlighted
by Bakken18 in his review of recent epidemiological
findings on the association of Chlamydia trachomatis
and ectopic pregnancy) are few.
We hypothesized that a higher proportion
of women with ectopic pregnancy had serological
evidence of previous infection with Chlamydia
trachomatis as compared to pregnant controls without
previous ectopic pregnancy. Our study therefore
aims to ascertain the association between serological
evidence of prior Chlamydia trachomatis infections and
the risk of  ectopic pregnancy. The result will be useful
in designing programmes to help reduce the burden
of Chlamydia trachomatis genital infections and by
extension ectopic pregnancy.
Methods
This case-control study was conducted in the two
main referral hospitals for gynecologic emergencies
in Benin City – the University of  Benin Teaching
Hospital, and the Central Hospital. The two hospitals
attend to >80% of  the gynaecological and obstetric
caseloads in Benin City and its environs. The cases
were 98 consecutive women with a diagnosis of
ectopic pregnancy confirmed at laparotomy in these
two hospitals during the period January 2010–June
2010.
The study was approved by the Ethical Review
Committee of  the University of  Benin Teaching
Hospital.
In all cases, the diagnosis of ectopic
pregnancy was confirmed by histological evaluation
of  the extirpated Fallopian tube specimen. Women
using an intrauterine contraceptive device (IUCD)
at the time of conception as well as those who had
blood transfusion within 6 months of the study were
excluded from the study. The control group was
made up of  women with confirmed uncomplicated
second trimester intrauterine pregnancy, without a
history of  previous ectopic pregnancy, attending the
antenatal clinic of  the aforementioned health facilities.
This group was made up of women without a
history of  infertility, tubal surgery or miscarriage.
Each case of ectopic pregnancy was immediately
followed by an age matched (± 2 years) pregnant
control attending the antenatal clinic.
Data collection
Informed consent was obtained from both cases
and controls upon recruitment into the study. They
were interviewed using a semi-structured
questionnaire. The questionnaire elicited information
on socio-demographic variables, sexual and
reproductive risk factors. In particular, the following
information was obtained: age, marital status,
educational level, and parity. Other information
solicited included, gestational age, age at sexual debut,
number of sexual partners, use of intrauterine
contraceptive device, history of previous ectopic
pregnancies, previous history suggestive of  pelvic
inflammatory disease and abdomino-pelvic surgery.
Macroscopic evidence of previous pelvic infection
(adhesions) was recorded at the time of the
operation.
Serological assay
Serological assay was performed with 5 ml (millilitre)
of venous blood which was collected from the volar
surface of  the forearms of  both cases and controls
and entered into clean and sterile plain specimen
bottle. The specimen was collected before blood
transfusion in patients with ectopic pregnancy. All
specimens were analyzed in the Medical
Microbiology and Parasitology Laboratory of  the
University of  Benin Teaching Hospital, by Medical
Microbiologists who worked in collaboration with
the authors. The blood specimen was allowed to
clot, and then centrifuged to obtain sera. The sera
were stored frozen at -20°C until analyzed in batches
for serum Chlamydia antibodies. The serological
assay was done using the Immunocomb Chlamydia
trachomatis Immunoglobulin G kit (Orgenics, Israel),
an indirect solid-phase enzyme immunoassay (EIA)
test that quantitatively measures antibodies to
Chlamydia trachomatis in human serum. The reagent
test kit was brought to room temperature and then
10µL (microlitre) pipetted serum was assayed with
reagent control samples for Chlamydia trachomatis
antibodies. The procedure was then run through a
number of timed steps as outlined by the
manufacturer. The results were recorded with the
aid of  calorimetric calibration scale in titres. The tests
were validated with the control samples. Significant
titre (positive results) was recorded as 1 in 32 or
greater.
Data management and analysis
Data analysis was done using the Statistical
Package for the Social Sciences (SPSS) version
16.  The results were aggregated and presented
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Where PAR% = the percent of the incidence of
a disease in the population (exposed and
nonexposed) that is due to exposure. It is the percent
of the incidence of a disease in the population that
would be eliminated if exposure were eliminated.
I
p 
= the incidence in total population (exposed and
unexposed) = 23.6 (From Darougar et al22)
in statements, frequency distribution tables and
cross tables.  Statistical test of  association was
carried out where applicable and the level of
significance set at p<0.05. Univariate analysis
of socio-demographic characteristics,
contraceptive and sexual history, as well as
prevalence of Chlamydia antibodies in patients
with ectopic gestation and pregnant controls
were also done. Conditional logistic regression
was used to calculate the odds ratio and 95%
confidence intervals. The characteristics of
women with Chlamydia antibodies were
analyzed in univariate logistic regression models.
Multivariate conditional logistic regression was used
to determine the association between Chlamydia
antibodies and ectopic pregnancy while controlling
for the effects of  background characteristics.
Results
Women’s Socio-demographic Characteristics
A total of 98 women with a diagnosis of ectopic
pregnancy (cases), confirmed at laparotomy, matched
with 98 pregnant controls were enrolled into the
study. Both groups were similar with regard to age:
the mean ± SD age for cases and controls was 28.3
± 3.4 years. The mean gestational age at presentation
for the ectopic pregnant patient was seven weeks
(range, 6-11 weeks) while the mean gestational age
at recruitment for the intrauterine pregnant controls
was 19.1weeks (range, 16 – 25 weeks). The women
with ectopic pregnancies were significantly more likely
to be single, more likely to be nulliparous, have less
than tertiary level education and are non-professionals
when compared with controls. There were nine cases
of repeat ectopic pregnancies giving a recurrent
ectopic pregnancy rate of 9.2%.
Sexual History
The mean age at sexual debut for the women with
ectopic pregnancy was 18.6 ± 2.0 years which
contrasted significantly with pregnant controls with
a mean age of 22.1± 4.5 years (p = 0.00).  Moreover,
women with ectopic pregnancy were more likely to
be at 13-17 years at sexual debut relative to ≥ 18
years in comparison with controls. In addition, 50.0%
(49/98) of women with ectopic pregnancy reported
having had three or more sexual partners in their
lifetime, compared with pregnant controls in which
16.3% (16/98) reported three or more lifetime sexual
partners. This difference was found to be statistically
significant (p<0.001). Despite this finding,
contraceptive uptake was poor in the study
population. The comparisons of the demographic
and sexual history between the ectopic and
intrauterine pregnant patients are shown in table 1.
Indicators of pelvic infection
Among the ectopic pregnant patients, 85.7% (84/
98) had at least one marker of previous pelvic
infection: vaginal discharge, lower abdominal pain,
dyspareunia and dysmenorrhea. By contrast, 58.2%
(57/98) of the pregnant controls reported previous
experience of  indicators of  pelvic infections. This
difference was statistically significant (p = 0.02). The
strongest differential between women with ectopic
pregnancies and pregnant controls was found for
vaginal discharge (p = 0.01).
Prevalence of Chlamydia antibodies
As shown in table 2, ectopic pregnant patients also
had a higher prevalence of exposure to Chlamydia
trachomatis (48.0%) as evidenced by the presence of
antibodies to Chlamydia trachomatis than did pregnant
controls (16.3%). The difference was statistically
significant (p<0.001).
The attributable risk percent (AR%) of ectopic
pregnancy arising from a positive Chlamydia IgG was
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Parameter Ectopic Pregnancy Intrauterine Pregnancy P value










































































































































































Table 1: Characteristics of  ectopic pregnant patients and intrauterine pregnant controls
OCP=Oral contraceptive pills




n % n %
Total 98 98
Positive 47 48.0 16 16.3 0.001
Negative 51 52.0 82 83.7
I
u
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Characteristics of women with Chlamydia
antibodies
Further analysis of the cases and controls showed
that the prevalence of anti-chlamydia antibodies was
significantly greater in ectopic pregnant patients (when
compared with controls) with a higher number of
life time sexual partners, to be 13 – 17 years at sexual
debut relative to ≥ 18 years and more likely to have
less than tertiary education as shown in table 3.
Among the 49 (50%) women with ectopic pregnancy
who reported having had three or more sexual
partners in their lifetime, 33 (70.2%) were positive
for Chlamydia trachomatis, whereas of the 16 (16.3%)
pregnant controls who reported a similar history of
sexual activity, only 4 (25.0%) were seropositive for
Chlamydia trachomatis (p = 0.002). Table 3 also shows
that, among the ectopic pregnant patients (compared
with controls), anti-chlamydia antibodies were more
likely to be present in parous women relative to
nulliparous, and these women were also more likely
never to have used a condom or oral contraceptive
pills. These associations were not statistically
significant. Of the indicators of pelvic infection, only
dysmenorrhea had a significant correlation with
positive antibodies to Chlamydia trachomatis antibodies
(p = 0.002). Vaginal discharge, lower abdominal pain
and dyspareunia were not significantly associated with
Chlamydia antibodies. Of  the nine patients with
repeat ectopic pregnancies, only two were positive
for antibodies to Chlamydia trachomatis
Table 3: Characteristics of  women with antibodies to Chlamydia trachomatis (n = 63)
Parameter Cases Controls P value
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Association of Chlamydia antibody with
previous history of  induced abortion
Among the ectopic pregnant patients, 57.1% (56/
98) self-reported a previous history of induced
abortion. Of these, 33 (58.9%) were positive for
Chlamydia antibodies.
Peritubal adhesions and antibodies to
Chlamydia trachomatis
Pelvic adhesions were visualized in 56 (57.1%)
women diagnosed with ectopic pregnancy at
laparotomy. The relationship between this finding
and antibodies to Chlamydia trachomatis is shown in
table 4. Severe adhesions were significantly associated
with increasing antibody titre, while women with no
adhesions had lower antibody titres (p<0.001).
However, it is noteworthy to mention that 21(21.3%)
of these women had a history of previous abdominal
surgeries.
Multivariate logistic regression analysis
The results of the bivariate analysis show that women
with ectopic pregnancy in comparison with controls
were more likely to be seropositive for exposure to
Chlamydia trachomatis, more likely to be single, have
less than tertiary level education, more likely to have
a higher level of  sexual activity, more likely to indicate
a previous history of vaginal discharge, more likely
to be nulliparous and are non-professionals.
Similarly, ectopic pregnant women who were
seropositive for antibodies to Chlamydia trachomatis
were more likely to have a higher number of life
time sexual partners, less than tertiary education, more
likely to be 13 – 17 years at sexual debut relative to
≥18 years, to report previous induced abortion and
a history of dysmenorrhea.
The results of logistic regression (table 5) revealed
more than four-fold increase in the risk of ectopic
pregnancy in those with antibodies to Chlamydia
trachomatis (OR= 4.5; CI 2.33 – 8.83) when controlling
for the markers of  pelvic infections. However, the
association between Chlamydia antibodies (OR =
2.82; 95% CI, 1.33 – 5.95) and ectopic pregnancy
was attenuated when the effects of markers of prior
pelvic infections, socio-demographic characteristics,
contraceptive and sexual history were controlled for.
Women with primary level of  education (OR = 6.32;
CI, 2.31 – 17.3), with three or more lifetime sexual
partners (OR = 5.71; CI, 2.39 – 13.65) and who
had a prior history of vaginal discharge (OR = 5.00;
CI, 2.03 – 12.3) were more likely to present with
ectopic pregnancy than women with antibodies to
Chlamydia trachomatis.
Table 4: Association of  antibodies to Chlamydia trachomatis with pelvic adhesions
Severity of pelvic 
adhesions
Serology Titre
<1/16 1/16 1/32 1/64 1/128 1/256
Normal pelvis 7 (33.3%) 23 (76.7%) 0 (0.0%) 12 (46.2%) 0 (0.0%) 0 (0.0%)
Grade I Pelvic 
adhesions
7 (33.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Grade II Pelvic 
adhesions
7 (33.3%) 7 (23.3%) 7 (100.0%) 14 (53.8%) 7 (100.0%) 7 (100.0%)
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13 – 17
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2.56 (1.26 – 5.20)
1.00
OCP = Oral contraceptive pill
Discussion
This study was designed to determine the association
between ectopic pregnancy and previous exposures
to Chlamydia trachomatis in Nigerian women. The exact
aetiology of  ectopic pregnancy remains unknown
and is surrounded in most part by controversy. Yet,
ectopic pregnancy continues to contribute to poor
reproductive performance amongst women of  child
bearing age in our community1,2. However, evidence
suggests an association between pelvic inflammatory
disease and ectopic pregnancy1,3. Efforts at
identifying the linkage, therefore, should attract
priority attention as its identification will encourage
the development of realistic policies to address the
problem.
We hypothesized that a higher proportion
of women with ectopic pregnancy will have
serological evidence of previous infection with
Chlamydia trachomatis as compared to pregnant
controls without previous ectopic pregnancy. The
results of the present study demonstrated an
association between ectopic pregnancy and the
presence of Chlamydia antibodies in the women
investigated. The prevalence of serum antibodies to
Chlamydia trachomatis in women with ectopic
pregnancy in this study was 48.0%, while it was
16.3% in women with normal intrauterine pregnancy.
Thus, the prevalence of serum antibodies to Chlamydia
trachomatis was high among patients with ectopic
pregnancy and significantly higher compared with
women with an uncomplicated intrauterine
pregnancy. This high rate is in keeping with data
presented in local studies and compares favourably
with various reports worldwide that patients with
ectopic pregnancy are more likely to have
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immunoglobulin G (IgG) antibodies against
Chlamydia trachomatis when compared with pregnant
controls9-12,23.
In addition, the results indicate that ectopic
pregnant women who were seropositive for
exposure to Chlamydia trachomatis had an increased
prevalence of pelvic adhesions compared with
ectopic patients who were negative for Chlamydia
antibodies.  There was also, as has been previously
reported24, a significant association between the
severities of tubal damage with regards to pelvic
adhesions and increasing antibody titre. This implies
that increasing antibody titres are quantitatively related
to both the presence of tubal damage and the severity
of tubal damage. While it can be argued that the
history of previous abdominal surgeries reported
by about a quarter of these women might be
contributory to the high rate of pelvic adhesions,
the correlation of severity of pelvic adhesions with
rising antibody cannot be explained by the effect of
previous surgery alone. Indeed data from a
comparative analysis of a large population of infertile
women concluded that chlamydia antibody titres are
of predictive value in the detection of tubal damage
and are quantitatively related to the severity of
damage24.
Given the large sample size of  this study, in
comparison with previous Nigerian studies, these data
strongly support the association between the
Chlamydia trachomatis and ectopic gestation and further
implicate antibodies to Chlamydia trachomatis in the
aetiology of  tubal disease and/or ectopic pregnancy.
Interestingly, the results of  the attributable and
population attributable risk and the multivariate
conditional logistic regression model suggest
otherwise. The attributable risk percent, a tool used
extensively by epidemiologists, which is the
proportion of the incidence of a disease in the
exposed that would be eliminated if exposure were
eliminated, was used to estimate the proportion of
ectopic pregnancies associated with and possibly
caused by chlamydial infection20. The attributable risk
amongst our patients who were chlamydial antibody
positive shows that 66 per cent of their ectopic
pregnancies were associated with exposure to
chlamydial infection. However, the most important
estimate from a public health perspective is the
population attributable risk, which measures the
proportion of all ectopic gestations associated with
chlamydial infection21. Previous studies have reported
population attributable risks showing that 61, 56 and
71 per cent of ectopic pregnancies are associated
with chlamydial infection23,25,26. This contrasts sharply
with the findings of this study where the population
attributable risk was 30.9%.  Such unusually low value,
though not unique to our population27, suggests that
chlamydial infections play only a minor role in the
pathogenesis of  ectopic pregnancy.
Furthermore, Chlamydia trachomatis is
certainly not the only cause of ectopic pregnancy as
demonstrated by the absence of antibodies to
Chlamydia trachomatis in 52% of ectopic pregnant
patients. Moreover, only two of  the nine patients
who had a recurrent ectopic pregnancy were
seropositive for Chlamydia antibodies. The
suggestion that Chlamydia infection may play a less
than significant role in the aetiology of  ectopic
pregnancy was again evident from the results of the
multivariate conditional logistic regression where the
strength of association between ectopic pregnancy
and Chlamydia antibodies was attenuated when the
effects of indicators of pelvic infections, socio-
demographic characteristics, contraceptive and sexual
history were combined. The results therefore suggest
that any effects of Chlamydia antibodies on ectopic
pregnancy are probably modulated through the
combined effects of socio-demographic
characteristics, sexual history and markers of previous
pelvic infections.
The results indicate that having primary level
of education was the strongest independent
predictor of ectopic pregnancy in the investigated
women, while the risks were also significantly
elevated in women with three or more lifetime sexual
partners and those with a previous history of vaginal
discharge. Women with a lower level of  education
may be more likely to acquire genital tract infections
that predispose them to increased risk of ectopic
pregnancy. Although the women in the present study
were not specifically asked questions on treatment
sources following gynaecological infections, previous
reports have suggested that women with lower levels
of education were more likely to seek ineffective
treatment from chemists and traditional healers than
obtain effective evidence-based formal health sector
treatment28. Thus less educated women may be more
likely to present with the sequalae of chronic pelvic
infections because of their greater likelihood to use
ineffective methods of treatment for genital tract
infections. Furthermore, the association between
ectopic pregnancy, self-report of  three or more
lifetime sexual partners and vaginal discharge suggest
that sexually transmitted organisms causing vaginal
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discharge are strongly associated with ectopic
pregnancy.
Therefore, this study’s finding is consistent
with previous reports in suggesting that these proxies
of sexually transmitted infections produce
gynaecological symptoms that may be due to other
genital tract infections rather than Chlamydia
trachomatis28-30. It is therefore plausible that in the
women with ectopic pregnancy and had negative
chlamydia serology, tubal damage may have been
caused by other organisms. Other pathogens
commonly implicated in the aetiology of
gynaecological symptoms in Nigeria include Nessieria
gonorrhea, Gram-negative organisms, viral agents and
pathogenic anaerobes. Recent reports have also
suggested that sexually transmitted Mycoplasma
genitalium may be an important cofactor and/or the
actual cause of salpingitis31. These infections may arise
from puerperal sepsis, pelvic inflammatory disease,
and post abortal sepsis. Indeed, a previous history
of induced abortion was a significant predictor of
ectopic pregnancy in this study, while a previous study
had suggested a strong association between vaginal
discharges and self-reports of induced abortion32.
Again, a previous analysis of the risk factors for
ectopic pregnancy provided evidence that previous
self-report of induced abortion and a previous
history of sexually transmitted diseases were
associated with increased risk of ectopic pregnancy8.
The results of this study therefore highlight the need
for the continued search for the pathogenic agent
most responsible for tubal disease and hence ectopic
pregnancy especially in the light of emerging evidence
of the increasing role of Mycoplasma genitalium. This
hypothesis is supported by evidence suggesting that
heat shock protein 60kDa antibodies might also be
elicited by other micro-organisms9.
Findings from ecological analyses such as
this must be interpreted with caution as the analyses
examine correlations between an exposure
(Chlamydia infection) and an outcome (ectopic
pregnancy). A potential problem is that these
associations may be confounded by factors that have
not been measured. These associations include sexual
behaviour and the use of contraception19. The use
of intrauterine devices increases the risk of an ectopic
implantation8, if implantation occurs, while greatly
reducing the probability of  any pregnancy occurring.
Thus women with IUCD were excluded from the
study. The potential effects of  confounders such as
condom use and other aspects of sexual behaviour
such as multiplicity of sexual partners were corrected
for by logistic regression models.
This study relied on the use of  serology which is less
sensitive than culture and nucleic acid amplification
tests in the diagnosis of  Chlamydia infections.
Currently, nucleic acid amplification tests are
considered the method of choice in the diagnosis
of Chlamydia infections because result specificities
approach 100%33. Unfortunately, these more
sensitive tests are more expensive than serological
tests and are also not available in many developing
countries28.  However, the assay used here is in line
with World Health Organization guidelines for
laboratory diagnosis of Chlamydia trachomatis infection
with performance characteristics reported as 73-83%
sensitivity and 97-99% specificity34.
Although it may be argued that the results
of  the present study, being a hospital based study,
cannot be extrapolated to the general population, it
is noteworthy to mention that the study was
conducted in the two tertiary care hospitals in Benin
City; UBTH and Central Hospital. The two hospitals
attend to >80% of  the gynaecological case loads in
Benin City and its environs. Therefore, allowing for
a minimal margin of error, the results of this study
may give a fairly true representation of the scenario
of the association of Chlamydia antibodies with
ectopic pregnancy in Benin City.
Conclusion
The present study demonstrated that a higher
proportion of women with ectopic pregnancy had
serological evidence of previous infection with
Chlamydia trachomatis as compared to pregnant
controls without previous ectopic pregnancy.
However, the results of the study failed to show a
strong independent association between Chlamydia
antibodies and the risk of  ectopic pregnancy. The
low population attributable risk suggests that
Chlamydia trachomatis infections are responsible for
only a small proportion of the rising incidence of
ectopic pregnancy observed in Benin City. The results
of the multivariate logistic regression model show
that having less than tertiary education, self-report
of three or more lifetime sexual partners and a
history of vaginal discharge were the strongest
markers of ectopic pregnancy in these women. The
implication is that these proxies of sexually
transmitted diseases produce gynaecological
symptoms that may be due to other genital tract
infections rather than Chlamydia trachomatis. Therefore
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efforts to address these factors through the provision
of sex education, prompt and effective treatment
of sexually transmitted infections and improvement
of health seeking behaviour for these infections will
likely contribute to reducing the burden of ectopic
pregnancy.
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